8Stock.Com Real Time Signal Analysis By Industry Sectors

8Stock.Com Real Time Signal Analysis
By Industry Sectors.

RSS Stock Market Analysis With Sector Related News Feed

Free Bursa Malaysia (KLSE) Hot Share Tips, Blogs / Forums, Research & Resources

Bursa Malaysia Free Hot Share Tips, Blogs / Forums, Research & KLSE Resources

INDUSTRY SECTOR Real Time Intraday Signal

US (Nasdaq, NYSE, AMEX) RSS News Feed

Live Link | INSURANCE | RSS News Feed | LTrader

HEALTH CARE, BIOTECHNOLOGY, DRUGS, PHARMACEUTICALS, MEDICAL

Live Link | HEALTH CARE | RSS News Feed | LTrader

Drug stocks turn higher; Cell Therapeutics, Novavax slide - MarketWatch

Drug stocks turn higher; Cell Therapeutics, Novavax slide
MarketWatch
The NYSE Arca Pharmaceutical Index (INDEX:DRG) and the NYSE Arca Biotechnology Index (INDEX:BTK) were both up 0.4% at ...

and more »

Drug stocks dip; BioMarin slides on downgrade - MarketWatch

Drug stocks dip; BioMarin slides on downgrade
MarketWatch
The NYSE Arca Pharmaceutical Index (INDEX:DRG) was down marginally at 299.43 and the NYSE Arca Biotechnology Index (INDEX:BTK) declined 1% to 956.63. ...
Benzinga's Top Downgrades (BMRN, AMB, DNB, ARG, HK)Benzinga
Stock Alert : Stocks Fall After Downgrade: BMRN, AMB, DNBTransWorldNews (press release)

all 9 news articles »

NexMed Receives over $2.7 Million Cash Infusion - MarketWatch

NexMed Receives over $2.7 Million Cash Infusion
MarketWatch
As stated previously, we have also received multiple expressions of interest from biotechnology and pharmaceutical companies who may be interested in ...

and more »

PPD Reports Fourth Quarter and Full Year 2009 Financial Results - MarketWatch

PPD Reports Fourth Quarter and Full Year 2009 Financial Results
MarketWatch
Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 40 countries and more ...

and more »

A modest debut for Ironwood's new stock - Boston Globe

The Money Times

A modest debut for Ironwood's new stock
Boston Globe
It was one of the most anticipated debuts of a biotechnology stock in years. But shares of Ironwood Pharmaceuticals Inc. advanced only ...
Ironwood's IPO DisappointsNew York Times (blog)
Ironwood prices IPO below expected rangeBusinessWeek
Ironwood Shares Rise After IPO Prices LowABC News
Motley Fool -Wall Street Journal -Xconomy
all 176 news articles »

Teva, Active extend pact on oral MS therapy - MarketWatch

Teva, Active extend pact on oral MS therapy
MarketWatch
TEL AVIV (MarketWatch) -- Teva Pharmaceutical Industries Ltd., (NASDAQ:TEVA) the Jerusalem drugmaker, extended its agreement to market and distribute ...
Teva extends oral laquinimod marketing rightsGlobes
TEVA ACQUIRES MARKETING RIGHTS FOR ORAL LAQUINIMOD IN THE NORDIC AND BALTIC ...PR-inside.com (press release)

all 39 news articles »

Novavax, Rovi end flu-vaccine-development plan - MarketWatch

Novavax, Rovi end flu-vaccine-development plan
MarketWatch
... (NASDAQ:NVAX) the Rockville, Md., biotech company focused on infectious diseases, said it ended talks aimed at a collaboration with Rovi Pharmaceuticals ...
Novavax Terminates Negotiations with ROVI Pharmaceuticals for Influenza ...PR Newswire (press release)
Novavax terminates license agreement with Laboratorios Farmaceuticos ROVITrading Markets (press release)

all 53 news articles »

Monday's biggest gaining and declining stocks - MarketWatch

Monday's biggest gaining and declining stocks
MarketWatch
Novavax Inc. (NASDAQ:NVAX) shares fell nearly 6% after the Rockville, Md., biotech company said it ended talks aimed at a collaboration with Rovi ...

and more »

QIAGEN Reports Strong Fourth Quarter and Fiscal 2009 Results - MarketWatch

QIAGEN Reports Strong Fourth Quarter and Fiscal 2009 Results
MarketWatch
Sales to customers in the pharmaceutical and biotech industry conducting clinical development continued to experience solid growth during the fourth quarter ...

and more »

Sunesis Grants Carmot Therapeutics License to Its Drug Discovery Technology - MarketWatch

Sunesis Grants Carmot Therapeutics License to Its Drug Discovery Technology
MarketWatch
... Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) today announced that it has granted Carmot Therapeutics, Inc., a privately-held biotechnology company, ...

and more »

Google News

TECHNOLOGY

World Wide Leader in Football match reviews, critics, reactions, rants